Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma

By: News Direct

March 09, 2023 at 07:53 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/proactives-robin-davison-publishes-fresh-research-note-on-poolbeg-pharma-346100498

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem ↗

Today 13:10 EDT

Via MarketBeat

Fortinet Sees Surging Hardware, SASE Demand as AI and OT Security Fuel Growth ↗

Today 13:02 EDT

Via MarketBeat

Birkenstock Beats the Skeptics—But Not on EPS ↗

Today 12:35 EDT

Via MarketBeat

EyePoint’s DURAVYU Misses Primary Endpoint in Phase III Wet AMD Trial ↗

Today 12:02 EDT

Via MarketBeat

Erdene Resource Development Q2 Earnings Call Highlights ↗

Today 12:02 EDT

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	258.73	-3.92 (-1.49%)
AAPL	304.63	-1.30 (-0.42%)
AMD	510.37	-4.02 (-0.78%)
BAC	64.56	+0.07 (0.10%)
GOOG	340.97	-2.57 (-0.75%)
META	565.66	-24.19 (-4.10%)
MSFT	479.48	-15.92 (-3.21%)
NVDA	226.07	+0.91 (0.40%)
ORCL	147.21	-3.31 (-2.20%)
TSLA	340.28	-1.99 (-0.58%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.